DK0469036T3 - Præparat og behandling med biologisk aktive peptider og antibiotika - Google Patents

Præparat og behandling med biologisk aktive peptider og antibiotika

Info

Publication number
DK0469036T3
DK0469036T3 DK90906603.7T DK90906603T DK0469036T3 DK 0469036 T3 DK0469036 T3 DK 0469036T3 DK 90906603 T DK90906603 T DK 90906603T DK 0469036 T3 DK0469036 T3 DK 0469036T3
Authority
DK
Denmark
Prior art keywords
biologically active
antibiotics
peptide
antibiotic
preparation
Prior art date
Application number
DK90906603.7T
Other languages
English (en)
Inventor
Michael Zasloff
Barry Berkowitz
Original Assignee
Philadelphia Children Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philadelphia Children Hospital filed Critical Philadelphia Children Hospital
Application granted granted Critical
Publication of DK0469036T3 publication Critical patent/DK0469036T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK90906603.7T 1989-04-17 1990-04-11 Præparat og behandling med biologisk aktive peptider og antibiotika DK0469036T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33929289A 1989-04-17 1989-04-17
US07/402,642 US5254535A (en) 1989-04-17 1989-09-05 Composition and treatment with biologically active peptides and antibiotic

Publications (1)

Publication Number Publication Date
DK0469036T3 true DK0469036T3 (da) 1996-04-01

Family

ID=26991557

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90906603.7T DK0469036T3 (da) 1989-04-17 1990-04-11 Præparat og behandling med biologisk aktive peptider og antibiotika

Country Status (12)

Country Link
US (1) US5254535A (da)
EP (1) EP0469036B1 (da)
JP (1) JPH04507087A (da)
KR (1) KR920700042A (da)
CN (1) CN1046462A (da)
AT (1) ATE135230T1 (da)
AU (1) AU5439490A (da)
CA (1) CA2013738A1 (da)
DE (1) DE69025927T2 (da)
DK (1) DK0469036T3 (da)
IL (1) IL93959A0 (da)
WO (1) WO1990012587A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ237202A (en) * 1990-02-23 1994-01-26 Bristol Myers Squibb Co Composition containing beta-lactam antibiotic and cationic oligopeptide
AU648140B2 (en) * 1991-02-01 1994-04-14 Virtual Drug Development, Inc. Reverse antimicrobial peptides and antimicrobial compositions
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
AU6251594A (en) * 1993-02-26 1994-09-14 Magainin Pharmaceuticals, Inc. Treatment of cancerous growths with biologically active peptides and protease inhibitors
AU7050294A (en) * 1993-06-04 1995-01-03 Demeter Biotechnologies, Ltd. Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides
US5834430A (en) * 1995-05-31 1998-11-10 Biosynth S.R.L. Potentiation of antibiotics
US6057291A (en) 1995-06-02 2000-05-02 University Of British Columbia Antimicrobial cationic peptides
JP3860838B2 (ja) 1995-08-23 2006-12-20 ユニバーシティー オブ ブリティッシュ コロンビア 抗微生物性陽イオン性ペプチドおよびそのスクリーニング方法
US8003595B2 (en) 2000-03-01 2011-08-23 Cellectis Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
US20040072815A1 (en) * 2002-02-12 2004-04-15 Koppel Gary A. Antibiotic composition and method
EP1360961A1 (en) * 2002-05-07 2003-11-12 AM-Pharma B.V. Use of antimicrobial peptides for potentiating the activity of antimicrobial agents
US8293700B2 (en) 2003-08-14 2012-10-23 Cellectis Anti-bacterial composition especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
FR2858772A1 (fr) * 2003-08-14 2005-02-18 Diatos Composition anti bacterienne, plus particulierement contre les bacteries gram negatif, comprenant un peptide et un agent anti-bacterien avantageusement hydrophobe
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
WO2010075416A1 (en) 2008-12-23 2010-07-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
GB201616014D0 (en) * 2016-09-20 2016-11-02 Helperby Therapeutics Ltd Combination
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
CN114432428A (zh) * 2022-02-24 2022-05-06 西北农林科技大学 PGLa提高细菌对抗生素的敏感性和延缓细菌耐药性产生的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4659692A (en) * 1982-11-19 1987-04-21 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
DE3324534A1 (de) * 1983-07-07 1985-01-17 Ciba-Geigy Ag, Basel Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel
US4617149A (en) * 1983-09-21 1986-10-14 Eli Lilly And Company Growth hormone release factor analogs
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
AU609118B2 (en) * 1987-03-04 1991-04-26 United States of America, as represented by the Secretary, U.S. Department of Commerce, The New synthetic bioactive compounds and method of producing bioactive effect

Also Published As

Publication number Publication date
AU5439490A (en) 1990-11-16
ATE135230T1 (de) 1996-03-15
EP0469036A1 (en) 1992-02-05
DE69025927T2 (de) 1996-08-01
US5254535A (en) 1993-10-19
EP0469036A4 (en) 1992-07-08
EP0469036B1 (en) 1996-03-13
IL93959A0 (en) 1990-12-23
DE69025927D1 (de) 1996-04-18
KR920700042A (ko) 1992-02-19
JPH04507087A (ja) 1992-12-10
CA2013738A1 (en) 1990-10-17
CN1046462A (zh) 1990-10-31
WO1990012587A1 (en) 1990-11-01

Similar Documents

Publication Publication Date Title
DK0469036T3 (da) Præparat og behandling med biologisk aktive peptider og antibiotika
ATE92080T1 (de) Isolierung und strukturbestimmung des zytostatischen linearen depsipeptids dolastatin 15.
DK0720482T3 (da) Prosaposin og cytokin-afledte peptider som terapeutiske midler
DK0695759T3 (da) Peptapeptid-methylestere, der inhiberer human cancer
BR9407278A (pt) Formulações farmacêuticas do fator de crescimento dos nervos
BG104370A (en) Composition improving the penetration into the skin
BR0214277A (pt) Solvatos de paclitaxel
DK366889A (da) Peptidderivat
DK0521994T3 (da) Farmaceutiske formuleringer
ATE218580T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
AU3228789A (en) Biologically active proteins
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
ZA200202255B (en) Manufacture and use of an antibiotic/antibiotics (or: antibiotic(s) preparation.
MY103769A (en) Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients
ES2111163T3 (es) Uso de fosfonatos para el tratamiento de la osteoporosis.
FI962354A0 (fi) Pitkävaikutteisia ruiskesuspensioita ja menetelmä niiden valmistamiseksi
DE68927759D1 (de) Cyclische Peptide mit Substance P-und Substance K-antagonistischer Aktivität
RU94040150A (ru) Стабильная лиофилизированная композиция тиотепа, способ ее получения
DE69621591D1 (de) Medikament welches Protein C aktivierendes Peptid enthält
NO931011L (no) 7-okso-7h-pyrido(1,2,3-de)(1,4)benzoksacin-6-karbonsyrer og -estere
KR900701300A (ko) 생물학적 활성 펩티드 및 특정음이온을 갖는 조성물 및 이것을 사용하는 방법
DK516288D0 (da) Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater
IE782423L (en) Tetrapeptide segment
KR900701299A (ko) Cpf 펩티드 조성물 및 이를 사용하는 방법
FI883247A (fi) 7-/1h-pyrrool-3-yl/-substituerade 3,5-dihydroxihept-6-ensyror, 7-/1h-pyrrol-3-yl/-susbtituerade 3,5 -dihydroxiheptansyror, motsvarande -laktoner och salter av dem, foerfarande foer framstaellning av dessa, deras anvaendning som laekemedel, farmaceutiska preparat och mellanprodukter.